ACRS
Aclaris Therapeutics Inc
NASDAQ · Pharmaceuticals
$3.57
+0.18 (+5.31%)
Open$3.36
Previous Close$3.39
Day High$3.65
Day Low$3.30
52W High$4.89
52W Low$1.05
Volume—
Avg Volume1.30M
Market Cap386.79M
P/E Ratio—
EPS$-1.38
SectorPharmaceuticals
Analyst Ratings
Strong Buy
13 analysts
Price Target
+398.3% upside
Current
$3.57
$3.57
Target
$17.79
$17.79
$13.99
$17.79 avg
$22.90
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 26.24M | 18.69M | 98.57M |
| Net Income | -185,107,858 | -118,633,534 | 16.17M |
| Profit Margin | -705.5% | -670.2% | 16.4% |
| EBITDA | -195,129,793 | -132,004,061 | 25.50M |
| Free Cash Flow | — | — | 16.19M |
| Rev Growth | +40.4% | +40.4% | -5.0% |
| Debt/Equity | — | — | 0.90 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |